Review: long-acting insulin analogues reduce risk for hypoglycemia compared with NPH insulin in type 2 diabetes

Affiliations

Comment

Jacqueline Pugh. ACP J Club. 2007 Sep-Oct.

. 2007 Sep-Oct;147(2):46.

¹ South Texas Veterans Health Care System & University of, Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

No abstract available

Comment on

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A. Horvath K, et al. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005613. doi: 10.1002/14651858.CD005613.pub3. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2020 Nov 9;11:CD005613. doi: 10.1002/14651858.CD005613.pub4. PMID: 17443605 Updated.